StonvexLoading…
StonvexStonvexStonvexCore line items from DHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $34.25B | $36.80B | $35.46B | $33.48B |
Operating Income | $4.74B | $6.28B | $6.31B | $7.63B |
Net Income | $3.59B | $4.76B | $4.75B | $5.86B |
EPS (Diluted) | $11.57 | $14.34 | $13.82 | $16.51 |
Total Assets | $35.47B | $36.10B | $32.58B | $30.35B |
Total Liabilities | $10.73B | $10.28B | $9.44B | $10.57B |
Cash & Equivalents | $2.99B | $4.52B | $3.87B | $2.54B |
Free Cash Flow OCF − CapEx | $3.28B | $2.02B | $4.16B | $413.60M |
Shares Outstanding | 294.48M | 324.03M | 334.85M | 343.95M |